^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    tasadenoturev (DNX-2401)

    i
    Company:
    DNAtrix
    Drug class:
    Immunostimulant, Cell death stimulant
    Related drugs:
    Apply
    MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma (NCT03896568)
    Phase 1
    M.D. Anderson Cancer Center
    Recruiting
    Last update posted :
    02/23/2024
    Initiation :
    02/12/2019
    Primary completion :
    09/30/2027
    Completion :
    09/30/2027
    IDH1
    |
    IDH wild-type
    |
    tasadenoturev (DNX-2401)
    DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors (TARGET-I) (NCT02197169)
    Phase 1b
    DNAtrix, Inc.
    Completed
    Last update posted :
    07/16/2018
    Initiation :
    09/11/2014
    Primary completion :
    03/15/2018
    Completion :
    03/15/2018
    IFNG
    |
    tasadenoturev (DNX-2401) • Actimmune (interferon gamma-1 b)